Skip to Main Content

Author Details

Eric Feyfant
Schrodinger Inc.
1997
22
14
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37439511Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development.J Med Chem2023
30380198The Role of Bridging Water and Hydrogen Bonding as Key Determinants of Noncovalent Protein-Carbohydrate Recognition.ChemMedChem2018
27964946Predicting the Effect of Amino Acid Single-Point Mutations on Protein Stability-Large-Scale Validation of MD-Based Relative Free Energy Calculations.J Mol Biol2017
29138295Generation of specific inhibitors of SUMO-1- and SUMO-2/3-mediated protein-protein interactions using Affimer (Adhiron) technology.Sci Signal2017
27217590Peripheral Administration of a Long-Acting Peptide Oxytocin Receptor Agonist Inhibits Fear-Induced Freezing.J Pharmacol Exp Ther2016
24443552A general approach to site-specific antibody drug conjugates.Proc Natl Acad Sci U S A2014
23946421Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.Proc Natl Acad Sci U S A2013
24099460Development of an informatics platform for therapeutic protein and peptide analytics.J Chem Inf Model2013
20981527Fragment-based drug design.Methods Mol Biol2011
19948242A structural informatics approach to mine kinase knowledge bases.Drug Discov Today2010
20629978A protein relational database and protein family knowledge bases to facilitate structure-based design analyses.Chem Biol Drug Des2010
19329309Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: a class of potent aggrecanase-1 inhibitors.Bioorg Med Chem Lett2009
18612831CONFIRM: connecting fragments found in receptor molecules.J Comput Aided Mol Des2008
17766392Modeling mutations in protein structures.Protein Sci2007
17531482Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors.Bioorg Med Chem Lett2007
17554852Lead optimization via high-throughput molecular docking.Curr Opin Drug Discov Devel2007
16723578Functional, biophysical, and structural bases for antibacterial activity of tigecycline.Antimicrob Agents Chemother2006
11839154Pharmacophore determination of a gp120 C terminal-derived anti-HIV peptide construct interfering with membrane fusion suggesting that processing of the gp120 C terminus is a prelude to fusion.AIDS Res Hum Retroviruses2002
10617625Formation of enzymatically active, homotypic, and heterotypic tetramers of mouse mast cell tryptases. Dependence on a conserved Trp-rich domain on the surface.J Biol Chem2000
10521469Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension.J Biol Chem1999
9395089Influence of a NH2-terminal extension on the activity of KTX2, a K+ channel blocker purified from Androctonus australis scorpion venom.FEBS Lett1997
9360993Mouse mast cell protease 9, a novel member of the chromosome 14 family of serine proteases that is selectively expressed in uterine mast cells.J Biol Chem1997
  • 1 - 22 of 22

Recommended Authors

Sarah Barelier
CNRS, Aix-Marseille University
Career Start Year 2009
Number of shared co-authors 0
Nir London
The Weizmann Institute of Science
Career Start Year 2007
Number of shared co-authors 1
Jacob D Durrant
University of Pittsburgh
Career Start Year 2006
Number of shared co-authors 1
Gerald H Lushington
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
Heather A Carlson
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 1
Matthew P Jacobson
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1999
Number of shared co-authors 3
Dmitri Beglov
Boston University
Career Start Year 1997
Number of shared co-authors 1
Roberto Sanchez
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 3
Andrew L Hopkins
University of Dundee
Career Start Year 1995
Number of shared co-authors 1
Shane Atwell
Lilly Research Laboratories
Career Start Year 1994
Number of shared co-authors 2
Aw Edith Chan
The Walter and Eliza Hall Institute of Medical Research
Career Start Year 1993
Number of shared co-authors 1
Robert Preissner
Institute for Physiology, Charite-University Medicine Berlin
Career Start Year 1990
Number of shared co-authors 0
Carlos J Camacho
University of Pittsburgh
Career Start Year 1990
Number of shared co-authors 0
Ram Samudrala
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Career Start Year 1990
Number of shared co-authors 1
Brian K Shoichet
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1989
Number of shared co-authors 1
Roland L Dunbrack
Fox Chase Cancer Center
Career Start Year 1989
Number of shared co-authors 4
John P Overington
Institute of Cardiovascular Science, University College London
Career Start Year 1988
Number of shared co-authors 1
Raymond C Stevens
iHuman Institute, ShanghaiTech University
Career Start Year 1988
Number of shared co-authors 2
Miriam Eisenstein
Weizmann Institute of Science
Career Start Year 1988
Number of shared co-authors 1
Gerhard Klebe
Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg
Career Start Year 1988
Number of shared co-authors 1
Herman W T van Vlijmen
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Career Start Year 1988
Number of shared co-authors 1
Andrew R Leach
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 1987
Number of shared co-authors 0
Stanley R Krystek
Bristol-Myers Squibb Pharmaceutical Research Institute
Career Start Year 1985
Number of shared co-authors 3
Mark S Johnson
Abo Akademi University
Career Start Year 1985
Number of shared co-authors 1
Christophe L M J Verlinde
University of Washington
Career Start Year 1984
Number of shared co-authors 1
Sandor Vajda
Boston University
Career Start Year 1982
Number of shared co-authors 3
Ruben Abagyan
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 0
James A Wells
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 1974
Number of shared co-authors 1
Tom L Blundell
Heartand Lung Research Institute, University of Cambridge
Career Start Year 1971
Number of shared co-authors 2
Jens Meiler
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 1

Collaborators

Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 4
Christine Humblet
Lilly Research Laboratories
Co-authored papers 4
Richard L Stevens
School of Biomedical Sciences and Pharmacy, University of Newcastle
Co-authored papers 3
Chifu Huang
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 3
Diane Joseph-McCarthy
Boston University
Co-authored papers 3
Daniel S Friend
Harvard Medical School
Co-authored papers 2
Yong Li
University of New South Wales
Co-authored papers 1
Andras Fiser
Albert Einstein College of Medicine
Co-authored papers 1
Wen-Tao Qiu
College of Life Science and Engineering, Foshan University
Co-authored papers 1
Michael F Gurish
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
M Ferrazzi
Institute of Infectious Diseases, University La Sapienza
Co-authored papers 1
Cindy Burklow
Co-authored papers 1
G Morales
Co-authored papers 1
Namit Ghildyal
Harvard Medical School
Co-authored papers 1
Victoria A Feher
University of California San Diego
Co-authored papers 1
A Vagi
Co-authored papers 1
K Chanasyk
Co-authored papers 1
K F Austen
Brigham & Women's Hospital
Co-authored papers 1
William W Wong
Johns Hopkins University School of Medicine
Co-authored papers 1
Lixin Li
Inc. 10555 Stella link
Co-authored papers 1
Steven A Krilis
University of NSW
Co-authored papers 1
Stephen U Stechschulte
worked together in the Northwest Haiti an Mission Hospital.
Co-authored papers 1
Y Tang
Co-authored papers 1
John E Hunt
Harvard Medical School
Co-authored papers 1
Release 1.2